Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2017
Source ID
10.1016/j.smim.2017.07.011

Entities

People

  • Daniel A. Vallera
  • Jeffrey S. Miller
  • Martin Felices
  • Zachary B. Davis

Organizations

  • National Institutes of Health
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech